Tissue Regenix Group (TRX)

 

TRX Share PerformanceMore

52 week high21.000 03/01/17
52 week low10.650 21/07/17
52 week change -9.015 (-44.52%)
4 week volume1,743,779 28/06/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Circ re.CellRight Acquisition

RNS Number: 8145L Tissue Regenix Group PLC 21 July 2017 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA. The information contained herein is not for release, directly or indi...

Successful fundraising of ?40 million

RNS Number: 7275L Tissue Regenix Group PLC 21 July 2017 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS...

Proposed Acquisition and Placing

RNS Number: 6900L Tissue Regenix Group PLC 20 July 2017 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS...

Result of AGM

RNS Number: 7516J Tissue Regenix Group PLC 30 June 2017 Tissue Regenix Group plc Result of AGM Leeds, 30 June 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, provides notification that, at the Group's AGM held earlier today, all resolutions were duly proposed to shareholders and passed. For...

Tissue Regenix widens FY pretax loss, revenue up

Tissue Regenix has reported a year of significant progress as it lifted revenue, but saw its pre-tax loss for the period widen. ...

Annual results for period ended 31 December 2016

RNS Number: 9671G Tissue Regenix Group PLC 02 June 2017 Tissue Regenix Group plc Annual results for period ended 31 December 2016 Group Revenues increase 77% Increased reimbursement coverage and penetration in key US markets Significant progress towards commercialisation of Orthopaedic products in the EU Leeds, 02 June 2017 - Tissue Regenix Group...

Tissue Regenix updates on potential acquisition of CellRight

Tissue Regenix Group said it has noted the recent dissolution of the temporary restraining order ("TRO") issued by Bexar ...

Potential Acquisition Update

RNS Number: 6845G Tissue Regenix Group PLC 31 May 2017 Tissue Regenix Group plc Potential Acquisition Update Leeds, 31 May 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, notes the recent dissolution of the temporary restraining order ("TRO") issued by Bexar County District Court agains...

Fundamental DataMore

EPS-1.27
Dividend yield0 %

Equity Research (TRX)

hardman & co
Tissue Regenix Group Plc
17/03/2017
TRX has a broad portfolio of regenerative medicine products developed from decellularised human and porcine tissues for the wound care, orthopaedics, and cardiac markets. Sales of DermaPure have...
edison investment research
Tissue Regenix Group Plc
03/02/2017
Edison Investment Research is terminating coverage on Tissue Regenix Group (TRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should...
edison investment research
Tissue Regenix Group Plc
19/10/2016
Tissue Regenix’s interim results are in line with our expectations and demonstrate the progress the company is making to achieve various milestones in each of its divisions. In particular, its Wound...

Latest discussion posts More

  • Re: ouch! Woodfords in

    Ouch indeed, I really reel for you LTH as I bought into this at 11p a few years ago and finally sold at 20p in April 2016 Looking at the recent events and the current sp TRX ...
    22-Jul-2017
    arborman
  • Re: ouch! Woodfords in

    Well Woodfords in. His name has more recently become synonymous with poor investment decisions rather than good. He is also getting bit not Lloyds. Notice a number of directors ...
    21-Jul-2017
    Chicken Lips
  • Re: ouch!

    I think there is compatibility in the tie up. Not sure about the business sense. Is the combined opportunity a stronger one; is this future proofing and greater profit - only ...
    21-Jul-2017
    Chicken Lips

Users' HoldingsMore

Users who hold Tissue Regenix Group also hold..
LLOYDS GRP.33%
BP22%
SIRIUS MINERALS19%
TAYLOR WIMPEY17%
TESCO17%

Codes & Symbols

ISINGB00B5SGVL29
SymbolsTRX, LSE:TRX, TRX.L, TRX:LN, LON:TRX, XLON:TRX